Unlocking the Treatment of Facioscapulohumeral Muscular Dystrophy Type 2: The Bisphenol Connection
View ORCID ProfileSaed Sayad, View ORCID ProfileMark Hiatt, View ORCID ProfileHazem Mustafa
doi: https://doi.org/10.1101/2024.03.12.24304159
Saed Sayad
1Bioada Lab
MD, PhDMark Hiatt
1Bioada Lab
MD, MBA, MSHazem Mustafa
1Bioada Lab
DDS, MScArticle usage
Posted March 13, 2024.
Unlocking the Treatment of Facioscapulohumeral Muscular Dystrophy Type 2: The Bisphenol Connection
Saed Sayad, Mark Hiatt, Hazem Mustafa
medRxiv 2024.03.12.24304159; doi: https://doi.org/10.1101/2024.03.12.24304159
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (718)
- Anesthesia (210)
- Cardiovascular Medicine (2995)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12891)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4684)
- Geriatric Medicine (431)
- Health Economics (738)
- Health Informatics (2980)
- Health Policy (1081)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (437)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4473)
- Nursing (239)
- Nutrition (656)
- Oncology (2322)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1212)
- Primary Care Research (509)
- Public and Global Health (7060)
- Radiology and Imaging (1570)
- Respiratory Medicine (930)
- Rheumatology (448)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (61)
- Transplantation (214)
- Urology (186)